Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNeuropharmacology

The Delta-Opioid Receptor Is Sufficient, but Not Necessary, for Spinal Opioid-Adrenergic Analgesic Synergy

Anne-Julie Chabot-Doré, Magali Millecamps and Laura S. Stone
Journal of Pharmacology and Experimental Therapeutics December 2013, 347 (3) 773-780; DOI: https://doi.org/10.1124/jpet.113.206581
Anne-Julie Chabot-Doré
Alan Edwards Centre for Research on Pain (A.-J.C.-D., M.M., L.S.S.), Integrated Program in Neuroscience (A.-J.C.-D.), McGill Scoliosis & Spine Research Group (M.M., L.S.S.), Faculty of Dentistry (M.M., L.S.S.), Departments of Anesthesiology (L.S.S.), Pharmacology & Therapeutics (L.S.S.), Neurology & Neurosurgery (A.-J.C.-D., L.S.S.), Faculty of Medicine (A.-J.C.-D., L.S.S.), McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magali Millecamps
Alan Edwards Centre for Research on Pain (A.-J.C.-D., M.M., L.S.S.), Integrated Program in Neuroscience (A.-J.C.-D.), McGill Scoliosis & Spine Research Group (M.M., L.S.S.), Faculty of Dentistry (M.M., L.S.S.), Departments of Anesthesiology (L.S.S.), Pharmacology & Therapeutics (L.S.S.), Neurology & Neurosurgery (A.-J.C.-D., L.S.S.), Faculty of Medicine (A.-J.C.-D., L.S.S.), McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura S. Stone
Alan Edwards Centre for Research on Pain (A.-J.C.-D., M.M., L.S.S.), Integrated Program in Neuroscience (A.-J.C.-D.), McGill Scoliosis & Spine Research Group (M.M., L.S.S.), Faculty of Dentistry (M.M., L.S.S.), Departments of Anesthesiology (L.S.S.), Pharmacology & Therapeutics (L.S.S.), Neurology & Neurosurgery (A.-J.C.-D., L.S.S.), Faculty of Medicine (A.-J.C.-D., L.S.S.), McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Spinal administration of opioid and α2-adrenergic receptor (α2AR) agonists produces analgesia, and agonists interact synergistically when coadministered. The molecular mechanism underlying this synergy is largely unknown. Pharmacological studies have identified both the delta and the mu-opioid receptors (DOR and MOR) as candidate receptors capable of interacting synergistically with α2AR agonists. However, recent studies attribute the antinociceptive effect of DOR agonists to actions at the MOR, calling the role of DOR in opioid-adrenergic synergy into question. Other studies suggesting that DOR is implicated in morphine antinociception raise the possibility that DOR is nonetheless required for morphine synergy with α2AR agonists. This study aimed to determine whether DOR activation is sufficient and necessary to mediate opioid-adrenergic synergistic interactions in the spinal cord. The antinociceptive effects of clonidine, [d-Ala2]-deltorphin II (DeltII), morphine, and [d-Ala2, N-Me-Phe4, Gly-ol5]-enkephalin (DAMGO) were evaluated using the substance P (SP) behavioral assay in wild type (WT) and DOR-knockout (KO) mice. Opioid-adrenergic drug interactions were evaluated after spinal coadministration of clonidine with DeltII, morphine, or DAMGO. Isobolographic analyses of dose-response curves determined whether interactions were synergistic or additive. The absence of DeltII antinociceptive efficacy in DOR-KO confirmed its selectivity in the SP assay. Although DeltII+clonidine interacted synergistically in WT mice, no interaction with clonidine was observed in DOR-KO mice. Clonidine was synergistic with morphine in both mouse strains. DAMGO did not synergize with clonidine in either strain. These findings confirm that although other opioid receptors can interact synergistically with α2AR agonists, DOR is sufficient for spinal opioid-adrenergic interactions.

Footnotes

    • Received June 28, 2013.
    • Accepted September 13, 2013.
  • This work was supported by Canadian Institutes for Health Research (CIHR) [Operating Grant MOP-86691], Bourse de chercheur-boursier from Fonds de Recherche en Santé du Québec (FRSQ), and Réseau de recherche en santé buccodentainre et osseuse (RSBO) infrastructure support (to L.S.S.). A.J.C.D. received studentship support from CIHR, the McGill University Integrated Program in Neuroscience (IPN), and the Louise and Alan Edwards Foundation and travel support from the Quebec Pain Research Network and the IPN.

  • This work was previously presented: Chabot-Doré A-J, Millecamps M, and Stone L (2012) Lack of opioid-adrenergic spinal analgesic synergy in d-opioid receptor knock-out mice (poster 882.22/DD15); 42nd Annual Meeting of the Society for Neuroscience; 13–17 October 2012; New Orleans, LA.

  • dx.doi.org/10.1124/jpet.113.206581.

  • Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 347 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 347, Issue 3
1 Dec 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Delta-Opioid Receptor Is Sufficient, but Not Necessary, for Spinal Opioid-Adrenergic Analgesic Synergy
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNeuropharmacology

Role of DOR in Opioid-Adrenergic Analgesic Synergy

Anne-Julie Chabot-Doré, Magali Millecamps and Laura S. Stone
Journal of Pharmacology and Experimental Therapeutics December 1, 2013, 347 (3) 773-780; DOI: https://doi.org/10.1124/jpet.113.206581

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNeuropharmacology

Role of DOR in Opioid-Adrenergic Analgesic Synergy

Anne-Julie Chabot-Doré, Magali Millecamps and Laura S. Stone
Journal of Pharmacology and Experimental Therapeutics December 1, 2013, 347 (3) 773-780; DOI: https://doi.org/10.1124/jpet.113.206581
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • M5 modulation of dopamine release in the striatum
  • Oxidative Stress and Nerve Agent Toxicity
  • PKA Is Responsible for the Presynaptic Inhibition by Xe
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics